These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27160923)

  • 61. Crystal structures of human saposins C andD: implications for lipid recognition and membrane interactions.
    Rossmann M; Schultz-Heienbrok R; Behlke J; Remmel N; Alings C; Sandhoff K; Saenger W; Maier T
    Structure; 2008 May; 16(5):809-17. PubMed ID: 18462685
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier.
    Yan H; Wang L; Wang J; Weng X; Lei H; Wang X; Jiang L; Zhu J; Lu W; Wei X; Li C
    ACS Nano; 2012 Jan; 6(1):410-20. PubMed ID: 22148835
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In Vitro and In Vivo Imaging of Fluorescent Aptamers.
    Théodorou I; Quang NN; Gombert K; Thézé B; Lelandais B; Ducongé F
    Methods Mol Biol; 2016; 1380():135-50. PubMed ID: 26552822
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel saposin-like protein of Entamoeba histolytica with membrane-fusogenic activity.
    Winkelmann J; Leippe M; Bruhn H
    Mol Biochem Parasitol; 2006 May; 147(1):85-94. PubMed ID: 16529828
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform.
    Bugaj JE; Achilefu S; Dorshow RB; Rajagopalan R
    J Biomed Opt; 2001 Apr; 6(2):122-33. PubMed ID: 11375721
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics.
    Hellebust A; Richards-Kortum R
    Nanomedicine (Lond); 2012 Mar; 7(3):429-45. PubMed ID: 22385200
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quantitative Studies on the Interaction between Saposin-like Proteins and Synthetic Lipid Membranes.
    Sandin SI; de Alba E
    Methods Protoc; 2022 Feb; 5(1):. PubMed ID: 35200535
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles.
    Blanco VM; Latif T; Chu Z; Qi X
    Transl Oncol; 2015 Jun; 8(3):196-203. PubMed ID: 26055177
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Glowing tumors make for better detection and resection.
    Bouvet M; Hoffman RM
    Sci Transl Med; 2011 Nov; 3(110):110fs10. PubMed ID: 22116932
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cancer optical imaging using fluorescent nanoparticles.
    Coll JL
    Nanomedicine (Lond); 2011 Jan; 6(1):7-10. PubMed ID: 21182412
    [No Abstract]   [Full Text] [Related]  

  • 71. Phosphatidylserine: A cancer cell targeting biomarker.
    Sharma B; Kanwar SS
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):17-25. PubMed ID: 28870843
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors.
    Abdelbaki MS; DeWire Schottmiller MD; Cripe TP; Curry RC; Cruze CA; Her L; Demko S; Casey D; Setty B
    Heliyon; 2022 Dec; 8(12):e12450. PubMed ID: 36590576
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy.
    Kaynak A; Davis HW; Kogan AB; Lee JH; Narmoneva DA; Qi X
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626139
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reuse of Molecules for Glioblastoma Therapy.
    Koehler A; Karve A; Desai P; Arbiser J; Plas DR; Qi X; Read RD; Sasaki AT; Gawali VS; Toukam DK; Bhattacharya D; Kallay L; Pomeranz Krummel DA; Sengupta S
    Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33525329
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of phosphatidylserine recognition receptors in multiple biological functions.
    Naeini MB; Bianconi V; Pirro M; Sahebkar A
    Cell Mol Biol Lett; 2020; 25():23. PubMed ID: 32226456
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy.
    N'Guessan KF; Patel PH; Qi X
    Cell Commun Signal; 2020 Jan; 18(1):6. PubMed ID: 31918715
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Review of the Application of Nanovesicles and the Human Interstitial Fluid in Gastrointestinal Premalignant Lesion Detection, Diagnosis, Prognosis and Therapy.
    Huang Y; Deng X; Liang J
    Int J Nanomedicine; 2019; 14():9469-9482. PubMed ID: 31819444
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles.
    Davis HW; Vallabhapurapu SD; Chu Z; Vallabhapurapu SL; Franco RS; Mierzwa M; Kassing W; Barrett WL; Qi X
    Oncotarget; 2019 Jan; 10(8):856-868. PubMed ID: 30783515
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment.
    Kumar S; Calianese D; Birge RB
    Immunol Rev; 2017 Nov; 280(1):149-164. PubMed ID: 29027226
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.